Sa Huang

No. 11 Fengxin Road
Guangzhou, 510663, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Hyaluronic acid-modified PLGA nanoparticles for enhanced ocular drug delivery.

Hyaluronic acid-modified PLGA nanoparticles for enhanced ocular drug delivery.

Journal: Journal of microencapsulation
Published: May 21, 2026

Celecoxib-Loaded "Nano-in-Nano" Hierarchical Delivery System: Structure-Driven Synergistic Optimization of Diffusion Efficiency and Mechanical Stability for Osteoarthritis Therapy.

Celecoxib-Loaded "Nano-in-Nano" Hierarchical Delivery System: Structure-Driven Synergistic Optimization of Diffusion Efficiency and Mechanical Stability for Osteoarthritis Therapy.

Journal: Drug design, development and therapy
Published: February 16, 2026

Phytochemical Optimization and Anti-Inflammatory Mechanism of an Aerial-Part Extract from Echinacea purpurea in DSS-Induced Colitis.

Phytochemical Optimization and Anti-Inflammatory Mechanism of an Aerial-Part Extract from Echinacea purpurea in DSS-Induced Colitis.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 26, 2025

Enhanced Ocular Bioavailability and Prolonged Duration via Hydrophilic Surface Nanocomposite Vesicles for Topical Drug Administration.

Enhanced Ocular Bioavailability and Prolonged Duration via Hydrophilic Surface Nanocomposite Vesicles for Topical Drug Administration.

Journal: Pharmaceutics
Published: October 26, 2024

Implantable celecoxib nanofibers made by electrospinning: fabrication and characterization.

Implantable celecoxib nanofibers made by electrospinning: fabrication and characterization.

Journal: Nanomedicine (London, England)
Published: February 02, 2024

Revealing Changes in Celecoxib Nanostructured Lipid Carrier's Bioavailability Using Hyaluronic Acid as an Enhancer by HPLC-MS/MS.

Revealing Changes in Celecoxib Nanostructured Lipid Carrier's Bioavailability Using Hyaluronic Acid as an Enhancer by HPLC-MS/MS.

Journal: Drug design, development and therapy
Published: January 30, 2024

Formation of Hydrophilic Nanofibers from Nanostructural Design in the Co-Encapsulation of Celecoxib through Electrospinning.

Formation of Hydrophilic Nanofibers from Nanostructural Design in the Co-Encapsulation of Celecoxib through Electrospinning.

Journal: Pharmaceutics
Published: January 15, 2023

Erratum: Long-term and potent IOP-lowering effect of IκBα-siRNA in a nonhuman primate model of chronic ocular hypertension.

Erratum: Long-term and potent IOP-lowering effect of IκBα-siRNA in a nonhuman primate model of chronic ocular hypertension.

Journal: iScience
Published: August 29, 2022

Long-term and potent IOP-lowering effect of IκBα-siRNA in a nonhuman primate model of chronic ocular hypertension.

Long-term and potent IOP-lowering effect of IκBα-siRNA in a nonhuman primate model of chronic ocular hypertension.

Journal: iScience
Published: December 23, 2021
Showing 1-9 of 9

Last Updated: 09/26/2026